Janus Henderson Global Life Sciences Fund
Janus Henderson Global Life Sciences Fund Fundamental Analysis
Janus Henderson Global Life Sciences Fund (JNGLX) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze JNGLX's fundamental strength across five key dimensions:
Efficiency Score
WeakJNGLX struggles to generate sufficient returns from assets.
Valuation Score
WeakJNGLX trades at a premium to fair value.
Growth Score
WeakJNGLX faces weak or negative growth trends.
Financial Health Score
WeakJNGLX carries high financial risk with limited liquidity.
Profitability Score
WeakJNGLX struggles to sustain strong margins.
Key Financial Metrics
Is JNGLX Expensive or Cheap?
No data available.
How Well Does JNGLX Make Money?
No data available.
Following the Money - Real Cash Generation
No data available.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
N/A
vs 25 benchmark
Current Ratio
Current assets to current liabilities
N/A
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
N/A
vs 25 benchmark
ROA
Return on assets percentage
N/A
vs 25 benchmark
ROCE
Return on capital employed
N/A
vs 25 benchmark
How JNGLX Stacks Against Its Sector Peers
| Metric | JNGLX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 18.86 | N/A |
| ROE | N/A | 847.00% | N/A |
| Net Margin | N/A | 4202.00% | N/A |
| Debt/Equity | N/A | 0.91 | N/A |
| Current Ratio | N/A | 667.17 | N/A |
| ROA | N/A | -21543.00% (disorted) | N/A |
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Janus Henderson Global Life Sciences Fund's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical